Hubei Biocause Pharmaceutical (000627) — Cash Flow-to-Debt Ratio
Hubei Biocause Pharmaceutical (000627) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2023, meaning its operating cash flow of CN¥276.06 Million could theoretically repay 0% of its total liabilities (CN¥272.50 Billion) in one year. Explore 000627 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hubei Biocause Pharmaceutical Cash Flow-to-Debt Ratio (2001–2023)
Historical debt coverage capacity for Hubei Biocause Pharmaceutical across 18 annual periods. Also explore Hubei Biocause Pharmaceutical asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Hubei Biocause Pharmaceutical (2001–2023)
Year-by-year debt coverage analysis for Hubei Biocause Pharmaceutical. For market capitalisation and broader financial context, see 000627 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | 0.04x | CN¥9.53 Billion | CN¥268.30 Billion | ▲ +20.0% |
| 2022 | 0.03x | CN¥7.52 Billion | CN¥254.00 Billion | ▲ +60.8% |
| 2021 | 0.02x | CN¥4.17 Billion | CN¥226.43 Billion | ▼ -82.4% |
| 2020 | 0.10x | CN¥21.42 Billion | CN¥204.81 Billion | ▼ -37.5% |
| 2019 | 0.17x | CN¥28.60 Billion | CN¥170.92 Billion | ▲ +70.0% |
| 2018 | 0.10x | CN¥14.98 Billion | CN¥152.24 Billion | ▲ +2492.8% |
| 2017 | 0.00x | CN¥431.58 Million | CN¥113.71 Billion | ▲ +115.8% |
| 2016 | -0.02x | CN¥-2.34 Billion | CN¥97.48 Billion | ▲ +67.8% |
| 2015 | -0.07x | CN¥-46.73 Million | CN¥625.50 Million | ▼ -141.3% |
| 2013 | 0.18x | CN¥130.53 Million | CN¥720.71 Million | ▲ +1.8% |
| 2012 | 0.18x | CN¥93.79 Million | CN¥527.37 Million | ▲ +24.7% |
| 2011 | 0.14x | CN¥66.95 Million | CN¥469.47 Million | ▼ -76.2% |
| 2010 | 0.60x | CN¥224.58 Million | CN¥374.25 Million | ▲ +132.1% |
| 2007 | 0.26x | CN¥118.56 Million | CN¥458.52 Million | ▼ -10.5% |
| 2006 | 0.29x | CN¥128.19 Million | CN¥443.66 Million | ▲ +111.8% |
| 2005 | 0.14x | CN¥48.66 Million | CN¥356.70 Million | ▼ -13.0% |
| 2004 | 0.16x | CN¥56.07 Million | CN¥357.41 Million | ▼ -4.9% |
| 2001 | 0.16x | CN¥37.30 Million | CN¥226.09 Million | — |